Literature DB >> 30292638

The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice.

Bangwei Luo1, Zhishang Wang2, Zhiyuan Zhang3, Zigang Shen2, Zhiren Zhang4.   

Abstract

Obesity has been linked with altered acute inflammation resolution which contributes to obesity-related clinical complications; however, the mechanisms that contribute to obesity-related unresolved inflammation are not fully known. Here we demonstrated that the deficiency of macrophage erythropoietin (EPO) signaling contributed to delayed acute inflammation resolution in diet-induced obese mice. In zymosan-induced acute peritonitis, in line with the delayed resolution of inflammation, the induction of macrophage EPO signaling was significantly reduced in obese mice relative to normal mice. Exogenous EPO induced macrophage EPO signaling and promoted acute inflammation resolution in obese mice. Efferocytosis of apoptotic cells by macrophages which is central in inflammation resolution was impaired in obese mice and restored by exogenous EPO. Mechanistically, macrophage peroxisome proliferator-activated receptor-γ (PPARγ) was greatly reduced in obese mice and EPO increased macrophage PPARγ to promote efferocytosis in obese mice. Together, our results identify an important mechanism underlying aberrant acute inflammation resolution in obesity, with important implications for regulating unresolved acute inflammation and normalizing macrophage defects in obese and diabetic individuals.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Erythropoietin; Inflammation resolution; Macrophage; Obesity

Mesh:

Substances:

Year:  2018        PMID: 30292638     DOI: 10.1016/j.bbadis.2018.10.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  6 in total

Review 1.  Drugging the efferocytosis process: concepts and opportunities.

Authors:  Parul Mehrotra; Kodi S Ravichandran
Journal:  Nat Rev Drug Discov       Date:  2022-06-01       Impact factor: 112.288

Review 2.  Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?

Authors:  Danfeng Lin; Xiaodiao Kang; Lu Shen; Sheng Tu; Cameron Lenahan; Yiding Chen; Xiaochen Wang; Anwen Shao
Journal:  Mol Ther Oncolytics       Date:  2020-04-28       Impact factor: 7.200

Review 3.  Adipocytes Are the Control Tower That Manages Adipose Tissue Immunity by Regulating Lipid Metabolism.

Authors:  Jeu Park; Jee Hyung Sohn; Sang Mun Han; Yoon Jeong Park; Jin Young Huh; Sung Sik Choe; Jae Bum Kim
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

Review 4.  Efferocytosis and Its Role in Inflammatory Disorders.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Front Cell Dev Biol       Date:  2022-02-25

5.  Erythropoietin promotes M2 macrophage phagocytosis of Schwann cells in peripheral nerve injury.

Authors:  Prem Kumar Govindappa; John C Elfar
Journal:  Cell Death Dis       Date:  2022-03-16       Impact factor: 9.685

Review 6.  Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.